The Use of Anticoagulants and Antiplatelet Agents among Outpatients in Alkharj

被引:0
|
作者
Ahmed, Nehad J. [1 ]
机构
[1] Prince Sattam Bin Abdulaziz Univ, Coll Pharm, Dept Clin Pharm, Alkharj, Saudi Arabia
关键词
Anticoagulant; antiplatelet; use; pattern; PREVENTION; THERAPY; STROKE; DRUGS;
D O I
10.9734/JPRI/2020/v32i1330580
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Background: Thromboembolic diseases are a leading cause of mortality and morbidity worldwide. Anticoagulants and antiplatelet medications are important therapies in the prevention and treatment of cerebrovascular and cardiovascular diseases. There is a limited data about the prescribing of these medications. Aim: This study aims to describe the pattern of anticoagulants and antiplatelet agents use among outpatients in Alkharj. Methodology: This is a retrospective study that includes the electronic prescriptions among outpatients in a public hospital in Alkharj Results: Aspirin was the most commonly prescribed agent (61.73%) followed by clopidogrel (18.60%) and enoxaparin (69%). Aspirin and clopidogrel was the most commonly prescribed combination (77.27%). Antiplatelet agents and anticoagulants result in improve several benefits but also could result in severe adverse effects and several drug interactions. Conclusion: The prescribers should ensure that benefit of Antiplatelet and anticoagulant outweigh the bleeding risk before prescribing these medications. It is important also to implement educational interventions to improve their use.
引用
收藏
页码:36 / 40
页数:5
相关论文
共 50 条
  • [1] Use of Anticoagulants and Antiplatelet Agents in Stable Outpatients with Coronary Artery Disease and Atrial Fibrillation. International CLARIFY Registry
    Fauchier, Laurent
    Greenlaw, Nicola
    Ferrari, Roberto
    Ford, Ian
    Fox, Kim M.
    Tardif, Jean-Claude
    Tendera, Michal
    Steg, Ph. Gabriel
    PLOS ONE, 2015, 10 (04):
  • [2] Antiplatelet agents and anticoagulants for hypertension
    Lip, Gregory Y. H.
    Felmeden, Dirk C.
    Dwivedi, Girish
    COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2011, (12):
  • [3] New anticoagulants and antiplatelet agents
    Linda Shore-Lesserson
    Canadian Journal of Anesthesia, 2004, 51 (Suppl 1): : R35 - R39
  • [4] Thrombolytics, anticoagulants, and antiplatelet agents
    Ringleb, PA
    STROKE, 2006, 37 (02) : 312 - 313
  • [5] Antiplatelet agents and anticoagulants for hypertension
    Shantsila, Eduard
    Koziel-Siolkowska, Monika
    Lip, Gregory Y. H.
    COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2022, (07):
  • [6] The Duration of Azithromycin use for Outpatients in a Public Hospital in Alkharj
    Ahmed, Nehad J.
    JOURNAL OF PHARMACEUTICAL RESEARCH INTERNATIONAL, 2021, 33 (08) : 7 - 11
  • [7] The Use of Anticoagulants and Antiplatelet Agents before Removal of EVDs - How Safe is It?
    Miller, Catherine Ann
    Tummala, Ramachandra
    JOURNAL OF NEUROSURGERY, 2015, 123 (02) : A505 - A506
  • [8] Endoscopy in Patients on Antiplatelet Agents and Anticoagulants
    Andrew M. Veitch
    Current Treatment Options in Gastroenterology, 2017, 15 (2) : 256 - 267
  • [9] New anticoagulants in combination with antiplatelet agents
    Johansen, Henriette
    Rutherford, Ole-Christian Walter
    Aamodt, Anne Hege
    Russell, David
    Atar, Dan
    Ghanima, Waleed
    TIDSSKRIFT FOR DEN NORSKE LAEGEFORENING, 2016, 136 (18) : 1543 - 1546
  • [10] Use of anticoagulants and antiplatelet agents in stable outpatients with coronary artery disease and atrial fibrillation. Data from the international CLARIFY registry
    Fauchier, L.
    Greenlaw, N.
    Ferrari, R.
    Ford, I.
    Fox, K.
    Tardif, J. C.
    Tendera, M.
    Steg, P. G.
    EUROPEAN HEART JOURNAL, 2013, 34 : 97 - 97